Product image of Hydrosan (Chlortalidone) supplied by GNH India

Hydrosan

Active Ingredient:
Chlortalidone
Origin:
EU

Hydrosan (Chlortalidone)

Chlortalidone, the active ingredient in Hydrosan, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower elevated blood pressure and to reduce fluid accumulation in conditions such as hypertension and edema in adult patients, and is indicated for use in adult patients requiring long‑term blood pressure control.

GNH India supplies Hydrosan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Wabosan Arzneimittelvertriebs Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Chlortalidone is a thiazide‑like diuretic that acts on the renal distal convoluted tubule to manage fluid balance and blood pressure.
  • Hypertension: reduces systolic and diastolic blood pressure in patients with elevated readings.
  • Edema: promotes diuresis to decrease fluid overload associated with cardiac or renal conditions.
  • Congestive heart failure: used as an adjunct to control volume status and improve symptoms.

How It Works

  • Chlortalidone blocks the NaCl cotransporter in the distal convoluted tubule of the kidney, decreasing sodium and chloride reabsorption. This leads to increased excretion of water and electrolytes, lowering plasma volume and peripheral vascular resistance, which together contribute to a reduction in blood pressure.

Side Effects

Common Side Effects

  • Increased urination: more frequent need to void.
  • Electrolyte imbalance: mild changes in potassium or sodium levels.
  • Dizziness or light‑headedness: especially after standing.
  • Headache: transient mild pain.
  • Fatigue: feeling unusually tired.
  • Gastrointestinal discomfort: nausea or abdominal cramps.

Serious or Rare Side Effects

  • Severe dehydration: marked fluid loss requiring medical attention.
  • Significant electrolyte disturbances: hyponatremia, hypokalemia, or hyperuricemia.
  • Gout flare: sudden joint pain due to uric acid elevation.
  • Allergic reactions: rash, itching, or swelling.
  • Pancreatitis: rare inflammation of the pancreas.
  • Acute kidney injury: sudden decline in renal function.

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Monitor electrolytes: regular blood tests for sodium, potassium, and uric acid.
  • Assess renal function: evaluate creatinine clearance prior to use.
  • Use cautiously in gout: may precipitate attacks.
  • Adjust dose in hepatic impairment: consider reduced dosing.
  • Avoid abrupt discontinuation: taper to prevent rebound hypertension.
  • Store at room temperature: keep below 25°C, in the original pack, protected from moisture.

Avoid Interactions

Chlortalidone may interact with several medicines. Review the following categories:

Major Interactions (Avoid)

  • Lithium: increased lithium levels and toxicity.
  • NSAIDs: reduced diuretic efficacy and possible renal impairment.
  • ACE inhibitors or ARBs: heightened risk of hypotension and renal dysfunction.
  • Digoxin: elevated serum digoxin concentrations.
  • Warfarin: potential alteration of anticoagulant effect.

Moderate Interactions (Monitor Closely)

  • Antidiabetic agents: enhanced hypoglycemic effect.
  • Corticosteroids: additive fluid retention.
  • Other antihypertensives: additive blood pressure lowering.
  • Antiepileptics: possible reduction in seizure threshold.
  • Calcium channel blockers: increased risk of hypotension.

Frequently Asked Questions

Hydrosan contains chlortalidone, a thiazide‑like diuretic indicated for the treatment of hypertension and for reduction of edema associated with various conditions such as heart failure or renal disease. It helps lower blood pressure and promote fluid excretion.

Chlortalidone inhibits sodium‑chloride reabsorption in the distal convoluted tubule of the kidney, leading to increased excretion of sodium, chloride, and water. This diuretic effect reduces plasma volume and peripheral resistance, thereby lowering blood pressure.

The exact dose of Hydrosan is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Dosage adjustments are made according to professional guidelines and patient monitoring.

Safety of chlortalidone in pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Hydrosan product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with classic thiazide diuretics such as hydrochlorothiazide, chlortalidone has a longer half‑life and a more potent natriuretic effect, which can provide more sustained blood‑pressure control. Choice of therapy depends on patient profile, efficacy, tolerability and cost considerations.

Hydrosan should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiration date.

Hydrosan is taken orally, usually with a full glass of water. It may be taken with or without food, but consistency with respect to meals helps maintain stable absorption. Patients should follow the prescriber’s instructions regarding timing and dosage.

Serious adverse reactions can include severe electrolyte disturbances such as hyponatremia or hypokalemia, acute kidney injury, gout attacks, and rare cases of allergic reactions or pancreatitis. Prompt medical attention is required if symptoms such as muscle weakness, severe abdominal pain, or rash develop.

Hydrosan is contraindicated in patients with known hypersensitivity to chlortalidone or other sulfonamide‑derived drugs, in those with severe renal impairment, anuria, or in individuals with uncontrolled gout. Clinicians should evaluate each patient’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chlortalidone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT